- Proportion of patients with evidence of treatment-emergent integrase inhibitor resistance
- Proportion of patients with evidence of treatment emergent resistance to the background regimen
- Incidence of disease progressions (HIV-associated conditions, AIDS, and death)
- Change in baseline CD4 count